Evidence map›Paper›PMID 38257792›Full record

ArticleViruses2024

Performance Analysis of Serodiagnostic Tests to Characterize the Incline and Decline of the Individual Humoral Immune Response in COVID-19 Patients: Impact on Diagnostic Management.

Ronald von Possel, Babett Menge, Christina Deschermeier, Carlos Fritzsche, Christoph Hemmer, Hilte Geerdes-Fenge, Micha Loebermann, Anette Schulz, Erik Lattwein, Katja Steinhagen and 3 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Ronald von PosselDepartment for Virology, Bernhard Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany.ORCID 0000-0001-9422-9401
Babett MengeInstitute for Experimental Immunology, EUROIMMUN Medizinische Labordiagnostika AG, 23560 Lübeck, Germany.
Christina DeschermeierDiagnostics Development Laboratory, Bernhard Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany.
Carlos FritzscheDepartment of Tropical Medicine and Infectious Diseases, Center of Internal Medicine II, University of Rostock, 18057 Rostock, Germany.
Christoph HemmerDepartment of Tropical Medicine and Infectious Diseases, Center of Internal Medicine II, University of Rostock, 18057 Rostock, Germany.
Hilte Geerdes-FengeDepartment of Tropical Medicine and Infectious Diseases, Center of Internal Medicine II, University of Rostock, 18057 Rostock, Germany.
Micha LoebermannDepartment of Tropical Medicine and Infectious Diseases, Center of Internal Medicine II, University of Rostock, 18057 Rostock, Germany.ORCID 0000-0002-3453-8998
Anette SchulzInstitute for Experimental Immunology, EUROIMMUN Medizinische Labordiagnostika AG, 23560 Lübeck, Germany.
Erik LattweinInstitute for Experimental Immunology, EUROIMMUN Medizinische Labordiagnostika AG, 23560 Lübeck, Germany.ORCID 0000-0003-0011-7420
Katja SteinhagenInstitute for Experimental Immunology, EUROIMMUN Medizinische Labordiagnostika AG, 23560 Lübeck, Germany.
Ralf Tönniesmedac GmbH, 22880 Wedel, Germany.
Reiner Ahrendtmedac GmbH, 22880 Wedel, Germany.
Petra EmmerichDepartment for Virology, Bernhard Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany.
University of Rostock · DEEuroimmun Medizinische Labordiagnostika (Germany) · DEMedac (Germany) · DEBernhard Nocht Institute for Tropical Medicine · DE

Funding

Federal Ministry of Education and Research 01KI20210
6 · The paper itself

Abstract

Serodiagnostic tests for antibody detection to estimate the immunoprotective status regarding SARS-CoV-2 support diagnostic management. This study aimed to investigate the performance of serological assays for COVID-19 and elaborate on test-specific characteristics. Sequential samples (

Indexed as

COVID-19COVID-19 TestingHumansImmunity, HumoralImmunoglobulin GSARS-CoV-2Serologic TestsImmunoglobulin GCOVID-19individual humoral immune responseserodiagnostic tests

Identifiers

PMID38257792
PMCPMC10820597
OpenAlexW4390671174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.